Delivery Order SPE2DB22D3501-SPE2DB25FVU44

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Drospirenone-EE 3-0.03 MG TAB 28S, a pharmaceutical product, with a ceiling value of $1,719.33 and a completion date of May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Drospirenone-EE 3-0.02 mg tablets in quantities of 28. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,566.38 and an ultimate completion date of October 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both entities are...
This is a $1,335.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and specialized medical equipment. Amerisourcebergen Drug Corp holds a significant...
This is a $1,729.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of pharmaceutical and medical products, including medications across multiple therapeutic categories such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, antibiotics, and specialized medical supplies....
This is a $1,265,131.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This award is part of Amerisourcebergen's larger $999,999,999.00...
This is a $27,021.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and covers the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $33,204.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a $1,363.12 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of various pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, vaccines, syringes, and other healthcare-related items. The contract is not set aside and represents open competition....
This is a $29,649.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,403.91 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, which has no set-aside designation, is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management, as well as specialized medical supplies. Amerisourcebergen Drug Corp holds a larger...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVU44
    Delivery Order

This is a $1,034.44 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DROSPIRENONE-EE 3-0.02 MG TAB 28S medication, with a performance period ending on May 27, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

The subject contract award is not designated as a set-aside, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp is a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/22/25, 10:00 AM